Navigation Links
Nieuwe behandeloptie vandaag geïntroduceerd voor artsen die patiënten behandelen met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom
Date:11/7/2012

SEATTLE, Washington, November 7, 2012 /PRNewswire/ --

Cell Therapeutics, Inc. ("CTI") (NASDAQ en MTA: CTIC), een bedrijf dat zich richt op het vertalen van wetenschap naar nieuwe kankertherapieën, heeft vandaag bekend gemaakt dat Pixuvri® (pixantron) in Nederland beschikbaar is. In mei 2012 is voor pixantron in de Europese Unie (EU) voorwaardelijke goedkeuring verleend en dit is de eerste, in de EU goedgekeurde behandeling voor volwassen patiënten met veelvuldig recidiverend of refractair agressief B-cel-non-hodgkinlymfoom ('NHL'). In het EXTEND (Expanding the reach of anthracyclines with piXanTronE in relapsed or refractory aggressive NHL Disease) -onderzoek naar pixantron bereikten met pixantron meer patiënten een volledige respons of niet-bevestigde volledige respons en duurde het ook langer voor hun ziekte verergerde dan met andere monotherapeutische behandelingen.[1]

"Er bestaat echt behoefte aan een nieuwe behandeloptie bij de behandeling van agressief recidiverend NHL," aldus Professor Anton Hagenbeek, hoogleraar hematologie verbonden aan het Academisch Medisch Centrum (AMC) in Nederland. "Momenteel zijn er voor patiënten die geen respons vertonen op tweedelijnsbehandeling en dus niet in aanmerking komen voor hooggedoseerde chemotherapie gevolgd door autologe stamceltransplantatie, maar beperkte opties en vaak kan hun alleen deelname aan een klinisch onderzoek of palliatieve zorg worden geboden. Pixantron is een belangrijke nieuwe ontwikkeling met objectieve responspercentages van 40% in deze specifieke subgroepen van 'poor-risk' patiënten waar zowel artsen als patiënten blij mee zullen zijn."

In de EU doen zich jaarlijks ongeveer 37.000 nieuwe gevallen van agressief B-cel-NHL voor.[2],[3] Patiënten met recidiverend/refractair NHL krijgen doorgaan
'/>"/>

SOURCE Cell Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Angeles, CA (PRWEB) July 22, 2014 ... test solutions with the debut of its fluorescent ... of Clinical Chemistry (AACC) meeting in Chicago, July ... or bench top versions, the HRDR-300 is a ... pending technology to analyze fluorescent lateral flow immunoassays ...
(Date:7/21/2014)... July 21, 2014 Lawrence ... Investment Board (WIB) and Las Positas College (LPC) ... technical education and hands-on training for veterans, officials ... Program at Las Positas is designed to ... for engineering technician careers, and establishes a pipeline ...
(Date:7/21/2014)... PHILADELPHIA , July 21, 2014  Mike ... closing of $1.6 million in Series Seed B ... and chemical sensors for the life science, defense, ... Trimaran Capital Partners led the round and was ... 36 Angels.  Said Patterson , "This round ...
(Date:7/19/2014)... 20, 2014 United States Non-Vascular ... GlobalDatas new report, "United States Non-Vascular Stents Market ... the United States Non-Vascular Stents market. The report ... (in units) and average prices (in US dollars) ... Stents and Metal Biliary Stents (Metal Non-Covered Biliary ...
Breaking Biology Technology:Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Engineering Program Established for Veterans 2Engineering Program Established for Veterans 3Global Graphene Manufacturing Leader, Graphene Frontiers, Receives Series Seed B Funding To Assure Production Of The Next Generation Of Biological And Chemical Sensor Technology 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4
... Quarter of 2007 -, - Tests Delivered Grew 68 Percent ... - Conference Call ... Genomic Health,Inc. (Nasdaq: GHDX ) today reported financial results and ... to $23.4 million in the first quarter of 2008,compared to $14.1 million ...
... CHAPEL HILL, N.C., May 6 There are a ... successful re-launch. An organization,s,sales force must be involved with ... crucial to any successful re-launch effort,according to a study ... you invigorate a sales force? Half of the companies ...
... ExonHit Therapeutics S.A.,(Alternext: ALEHT), a drug and ... its new SpliceArray(TM) for use in disease,modeling ... pre-clinical,research communities. These SpliceArray(TM) products provide the ... genome commercially,available today. ExonHit,s patented unique approach ...
Cached Biology Technology:Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 2Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 3Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 4Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 5Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 6Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 7Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 8Genomic Health Announces First Quarter 2008 Financial Results and Business Progress 9Invigorated Sales Force Key to a Successful Re-Launch 2ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics 2ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics 3
(Date:7/21/2014)... A University of California, San Diego School of Medicine-led ... not recognize the potentially serious health consequences of childhood ... in helping their child reach a healthy weight. , ... of the Academy of Nutrition and Dietetics . , ... and physical activity behaviors," said lead author Kyung Rhee, ...
(Date:7/21/2014)... cheating in science are among the topics to ... experts in Montreal at the three International Union ... to August 1, 2014. Some 2,000 participants from ... 14th International Congress of Bacteriology and Applied Microbiology, ... Microbiology, and the 16th International Congress of Virology. ...
(Date:7/21/2014)... 154 hotspots in areas across Riau province on Sunday, ... again following a decline in rainfall. The number ... than what had been reported one day prior, which ... scattered in six regencies and municipalities, most of which ... related haze it creates could potentially spread via winds ...
Breaking Biology News(10 mins):Parents rank their obese children as 'very healthy' 2Montreal hosts International Union of Microbiology Societies congresses 2
... Howard Hughes Medical Institute investigator Brian J. Druker and ... unknown genetic mutations that can trigger cancerous growth. By ... myeloid leukemia (AML) cells, the researchers have dramatically reduced ... abnormalities that might be vulnerable to specific drug treatments. ...
... shows the need for an international moratorium on bottom-trawling ... life, Conservation International (CI) said. , The U.N. Division ... reviewed measures to protect the vulnerable deep oceans of ... lies beyond the national jurisdictions of any individual nation. ...
... that it allows scientists peering inside cells to ... protein they are studying has been developed and ... Medical Institute's Janelia Farm Research Campus in collaboration ... and Florida State University. , The new technique ...
Cached Biology News:New strategy rapidly identifies cancer targets 2New strategy rapidly identifies cancer targets 3UN review shows need to halt destructive fishing practice 2New light microscope sharpens scientists' focus 2New light microscope sharpens scientists' focus 3New light microscope sharpens scientists' focus 4New light microscope sharpens scientists' focus 5New light microscope sharpens scientists' focus 6
Request Info...
Recombinant Equine TNF-alpha/TNFSF1A, CF...
Recombinant Equine IL-4, CF...
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
Biology Products: